Summary of Significant Accounting Policies (Tables)

3 Months Ended

Jun. 30, 2022

Accounting Policies [Abstract]

Summary of Significant Customer Information

Significant customer information is as follows:

	June 30,			March 31,
	2022			2022
Percentage of accounts receivable:
Customer C		71	%		25	%
Customer F		14	%		19	%
Customer G		0	%		44	%

	Three Months Ended June 30,
	2022			2021
Percentage of revenue:
Customer C		15	%		14	%
Customer B		13	%		19	%

Summary Of Revenue By Category

The following table presents revenue by category:

	Three Months Ended June 30,
	2022					2021
	Amount		% of Revenue			Amount		% of Revenue
	(in thousands, except percentages)
Point in Time
PGS	$	39,691		61	%	$	45,023		76	%
Telehealth (1)		9,361		15	%		—		0	%
Consumer services		49,052		76	%		45,023		76	%
Research services		—		0	%		—		0	%
Total (2)		49,052		76	%		45,023		76	%
Over Time
PGS		4,484		7	%		2,827		5	%
Telehealth (1)		2,523		4	%		—		0	%
Consumer services		7,007		11	%		2,827		5	%
Research services		8,454		13	%		11,389		19	%
Total (2)		15,461		24	%		14,216		24	%
Total Revenue
PGS		44,175		68	%		47,850		81	%
Telehealth (1)		11,884		19	%		—		0	%
Consumer services		56,059		87	%		47,850		81	%
Research services		8,454		13	%		11,389		19	%
Total (2)	$	64,513		100	%	$	59,239		100	%

(1) There was no telehealth revenue for the three months ended June 30, 2021, as the Lemonaid Acquisition closed in November 2021.

(2) There was no Therapeutics revenue for the three months ended June 30, 2022 and 2021.

Summary of Revenue by Region based on the Shipping Address of Customers

The following table summarizes revenue by region based on the shipping address of customers or the location where the services are delivered:

	Three Months Ended June 30,
	2022					2021
	Amount		% of Revenue			Amount		% of Revenue
	(in thousands, except percentages)
United States	$	48,108		75	%	$	40,352		68	%
United Kingdom		11,975		19	%		13,906		23	%
Canada		3,039		4	%		3,240		6	%
Other regions		1,391		2	%		1,741		3	%
International		16,405		25	%		18,887		32	%
Total	$	64,513		100	%	$	59,239		100	%

Schedule Of Company Revenue and Adjusted EBITDA by Segment

The Company’s revenue and Adjusted EBITDA by segment is as follows:

	Three Months Ended June 30,
	2022			2021
	(in thousands)
Segment Revenue
Consumer and Research Services	$	64,513		$	59,239
Total Revenue (1)	$	64,513		$	59,239
Segment Adjusted EBITDA
Consumer and Research Services Adjusted EBITDA	$	(16,997	)	$	(505	)
Therapeutics Adjusted EBITDA		(18,465	)		(18,303	)
Unallocated Corporate(1)		(14,253	)		(8,467	)
Total Adjusted EBITDA	$	(49,715	)	$	(27,275	)
Reconciliation of net loss to Adjusted EBITDA
Net Loss	$	(89,532	)	$	(42,026	)
Adjustments
Interest (income) expense, net		(245	)		(44	)
Other (income) expense, net		435			(14	)
Change in fair value of warrant liabilities		—			534
Income tax benefit		(254	)		—
Depreciation and amortization		5,104			4,638
Amortization of acquired intangible assets		4,315			—
Stock-based compensation expense		30,462			9,637
Total Adjusted EBITDA	$	(49,715	)	$	(27,275	)

(1) There was no Therapeutics revenue for the three months ended June 30, 2022 and 2021.

Summary of Customers Accounting for 10% or More of Segment Revenues

Customers accounting for 10% or more of segment revenues were as follows:

	Three Months Ended June 30,
	2022				2021
	(in thousands, except percentages)
Consumer and Research Services Segment Revenue:
Customer C(1)	$	9,628	15	%	$	8,512	14	%
Customer B(2)	$	8,246	13	%	$	11,209	19	%

(1)Customer C revenues are primarily in the United States.

(2)Customer B revenues are in the U.K.